Prevention

The National Changing Diabetes((R)) Program (NCDP), a program of Novo Nordisk, and several member associations recently urged President Obama and members of Congress to make the prevention, detection and treatment of diabetes, one of the nation’s most pervasive and costly diseases, a priority in reforming the U.S. healthcare system.

A free resource designed to educate patients about ways to successfully manage their diabetes was revealed at the American Association of Clinical Endocrinologists (AACE) 18th Annual Meeting & Clinical Congress: “The Power of Prevention Magazine”.…

Primary- and secondary-prevention patients who consistently take their statin medication have a significantly lower risk of death than those who do not adhere to therapy, a new study has shown [1]. Individuals who took their medication at least 90% of the time had a 45% reduction in the risk of …

The Endocrine Society has released a new clinical practice guideline for the primary prevention of cardiovascular disease and type 2 diabetes in patients at metabolic risk.

Neither vitamin E nor vitamin C supplements reduced the risk of major cardiovascular events in a large, long-term study of male physicians, according to a new study.

A new study has found no evidence that aspirin or antioxidants are of any benefit in the primary prevention of cardiovascular events in diabetic patients with asymptomatic peripheral arterial disease (PAD)

Insulin therapy doesn’t prevent type 1 diabetes in genetically high-risk infants showing early signs of the autoimmune disease, researchers found.

Community-based health programs aimed at diet, exercise, smoking prevention and other known risk factors for chronic diseases could cut health-care costs in the United States by $16 billion a year, at a cost of 10 dollars per patient/year, a new report says.

Pioglitazone (Actos) may prevent or delay progression to diabetes for patients with pre-diabetes by 81%, researchers found.

Aspirin-like compounds (salicylates) can claim another health benefit: increasing the amount of insulin produced by otherwise healthy obese people. Obesity is associated with insulin resistance, the first step toward type 2 diabetes.